In the quiet desperation that drives people toward unregulated remedies, one Australian patient paid a severe price — a torn oesophagus — after ingesting what they believed was an experimental weight loss peptide purchased online. When regulators tested the vial, they found not the promised compound but a different drug entirely, at eight times its approved concentration. The Therapeutic Goods Administration's subsequent warning speaks to something larger than one counterfeit product: it names the systemic danger of a shadow pharmaceutical market where hope is sold in unmarked vials and the co
Counterfeit weight loss peptide hospitalizes patient; TGA warns of serious risks
One patient was hospitalized with a torn oesophagus requiring medical treatment after ingesting counterfeit peptide product.